PRPO

Precipio, Inc. [PRPO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

PRPO Stock Summary

Top 10 Correlated Stocks

PRPO


In the News

10:00 29 Mar 2024 PRPO

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year.

06:38 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q3 2023 Earnings Conference Call November 20, 2023 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Operator Welcome to the Precipio Third Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode.

09:00 29 Mar 2024 PRPO

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that Q3-2023 (unaudited) revenues have increased 28% to $4.5M from $3.5M in Q2-2023, and have more than doubled from $2.2M from Q3-2022.

06:32 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q2 2023 Earnings Conference Call August 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Second Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode.

12:34 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q1 2023 Earnings Conference Call May 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Q1 2023 Shareholder Update Conference Call. All participants will be in listen-only mode.

07:10 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) Q4 2022 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q4 2022 Earnings Conference Call April 3, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio shareholder 2022 Fourth Quarter and Year-End Shareholder Update Conference Call. All participants will be in listen-only mode.

06:37 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) Q3 2022 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants Operator Welcome to the Precipio Shareholder Third Quarter 2022 Shareholder Update Conference Call. All participants will be in listen-only mode.

08:24 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2022 Results - Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Ilan Danieli - Founder, President, CEO & Director Conference Call Participants Operator Welcome to the Precipio Shareholder -- Second Quarter 2022 Shareholder Update Conference Call. (Operator Instructions) Please note that the conference is being recorded.

10:00 29 Mar 2024 PRPO

Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference

NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , is excited to announce its participation and the presentation of HemeScreen, its novel diagnostic technology platform, at the Executive War College , organized by publication Dark Daily, the premier laboratory conference, held April 26th through 28th in New Orleans.

07:30 29 Mar 2024 PRPO

Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2021 Results - Earnings Call Transcript

Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2021 Results - Earnings Call Transcript

PRPO Financial details

Company Rating
Neutral
Market Cap
8.55M
Income
-9.09M
Revenue
12.48M
Book val./share
9.28
Cash/share
1.12
Dividend
-
Dividend %
-
Employees
53
Optionable
No
Shortable
Yes
Earnings
01 Apr 2024
P/E
-0.88
Forward P/E
0.41
PEG
1.32
P/S
0.66
P/B
0.62
P/C
5.98
P/FCF
-1.55
Quick Ratio
0.56
Current Ratio
0.79
Debt / Equity
0.1
LT Debt / Equity
0.05
-
-
EPS (TTM)
-7.56
EPS next Y
16.4
EPS next Q
-0.7
EPS this Y
32.47%
EPS next Y
-316.93%
EPS next 5Y
-462.43%
EPS last 5Y
-45.23%
Revenue last 5Y
26.86%
Revenue Q/Q
5.8%
EPS Q/Q
-44.68%
-
-
-
-
SMA20
-4.35%
SMA50
5.12%
SMA100
-21.13%
Inst Own
0%
Inst Trans
0%
ROA
-48%
ROE
-63%
ROC
-0.67%
Gross Margin
37%
Oper. Margin
-73%
Profit Margin
-73%
Payout
-
Shs Outstand
1.42M
Shs Float
1.36M
-
-
-
-
Target Price
-
52W Range
4.752-15.42
52W High
-55.33%
52W Low
+67.5%
RSI
60.82
Rel Volume
1.57
Avg Volume
6.48K
Volume
10.18K
Perf Week
9.84%
Perf Month
3.88%
Perf Quarter
9.66%
Perf Half Y
11.48%
-
-
-
-
Beta
1.616
-
-
Volatility
0.23%, 0.23%
Prev Close
8.06%
Price
6.7
Change
11.48%

PRPO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
39.7510.987.398.398.27
Net income per share
-217.81-46.51-14.84-8.1-10.73
Operating cash flow per share
-93.73-32.1-9.02-6.23-6.79
Free cash flow per share
-95.08-32.29-9.21-6.88-7.03
Cash per share
5.292.983.2211.063.03
Book value per share
84.9846.3717.1623.2914.33
Tangible book value per share
-182.75-12.13-1.839.372.28
Share holders equity per share
84.9846.3717.1623.2914.33
Interest debt per share
48.696.432.381.371.23
Market cap
3.33M11.68M34.11M33.34M12.54M
Enterprise value
8.05M12.19M32.94M23.1M10.48M
P/E ratio
-0.21-0.88-2.79-3.9-1.03
Price to sales ratio
1.163.735.63.771.33
POCF ratio
-0.49-1.28-4.59-5.07-1.62
PFCF ratio
-0.49-1.27-4.5-4.59-1.57
P/B Ratio
0.540.882.411.360.77
PTB ratio
0.540.882.411.360.77
EV to sales
2.813.95.412.611.11
Enterprise value over EBITDA
-2.52-1.9-4.95-2.83-0.93
EV to operating cash flow
-1.19-1.33-4.43-3.51-1.36
EV to free cash flow
-1.18-1.33-4.34-3.18-1.31
Earnings yield
-4.71-1.13-0.36-0.26-0.97
Free cash flow yield
-2.06-0.79-0.22-0.22-0.64
Debt to equity
0.830.10.110.060.09
Debt to assets
0.240.070.070.050.06
Net debt to EBITDA
-1.48-0.080.181.250.18
Current ratio
0.130.430.93.21.31
Interest coverage
8.71-19.88-19.46-480.65-1.07K
Income quality
0.430.690.70.770.63
Dividend Yield
00.32000
Payout ratio
0-0.28000
Sales general and administrative to revenue
3.32.661.481.21.44
Research and developement to revenue
00.380.20.150.18
Intangibles to total assets
0.890.850.760.480.64
Capex to operating cash flow
0.010.010.020.10.04
Capex to revenue
-0.03-0.02-0.02-0.08-0.03
Capex to depreciation
-0.08-0.04-0.11-0.47-0.18
Stock based compensation to revenue
0.180.210.120.210.4
Graham number
645.32220.2875.765.1658.81
ROIC
-1.19-0.61-0.66-0.35-0.69
Return on tangible assets
-6.78-4.64-2.42-0.54-1.58
Graham Net
-201.03-17.33-3.726.29-0.49
Working capital
-11.97M-2.46M-452K9.27M1.35M
Tangible asset value
-13.17M-3.45M-1.51M9.89M2.6M
Net current asset value
-13.69M-4.43M-2.35M7.64M573K
Invested capital
0.830.10.110.060.09
Average receivables
710K632K724K785.5K866.5K
Average payables
5.14M3.55M1.81M1.78M1.95M
Average inventory
179K190.5K267K457K636K
Days sales outstanding
87.946752.3728.7540.18
Days payables outstanding
714.92243125.04105.31107.99
Days of inventory on hand
27.2523.0925.8531.8837.44
Receivables turnover
4.155.456.9712.79.08
Payables turnover
0.511.52.923.473.38
Inventory turnover
13.415.814.1211.459.75
ROE
-2.56-1-0.87-0.35-0.75
Capex per share
-1.35-0.19-0.18-0.65-0.24

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.952.12.432.92.68
Net income per share
-2.74-2.02-2.62-1.88-1.04
Operating cash flow per share
-1.97-1.31-1.36-0.99-0.64
Free cash flow per share
-2.07-1.36-1.38-1.01-0.66
Cash per share
4.523.021.842.111.12
Book value per share
15.9814.2912.211.519.28
Tangible book value per share
3.732.280.60.66-0.04
Share holders equity per share
15.9814.2912.211.519.28
Interest debt per share
1.41.231.030.880.92
Market cap
18.3M12.57M15.41M9.5M7.82M
Enterprise value
14.74M10.52M14.47M8M7.56M
P/E ratio
-1.47-1.36-1.27-1.04-1.34
Price to sales ratio
8.265.265.472.692.09
POCF ratio
-8.17-8.38-9.79-7.9-8.73
PFCF ratio
-7.76-8.1-9.65-7.7-8.51
P/B Ratio
1.010.771.090.680.6
PTB ratio
1.010.771.090.680.6
EV to sales
6.664.45.142.262.02
Enterprise value over EBITDA
-5.19-5.37-5.47-4.18-5.22
EV to operating cash flow
-6.58-7.01-9.19-6.65-8.43
EV to free cash flow
-6.25-6.78-9.06-6.48-8.22
Earnings yield
-0.17-0.18-0.2-0.24-0.19
Free cash flow yield
-0.13-0.12-0.1-0.13-0.12
Debt to equity
0.090.090.080.080.1
Debt to assets
0.070.060.060.050.07
Net debt to EBITDA
1.251.050.360.790.18
Current ratio
1.681.310.890.920.79
Interest coverage
-538.17-387.67756.5-2.29K206.86
Income quality
0.710.660.520.520.62
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
01.03000
Research and developement to revenue
00.71000
Intangibles to total assets
0.590.640.70.680.69
Capex to operating cash flow
0.050.030.010.030.03
Capex to revenue
-0.05-0.02-0.01-0.01-0.01
Capex to depreciation
-0.31-0.14-0.06-0.08-0.06
Stock based compensation to revenue
0.330.170.160.10.1
Graham number
31.4125.526.8122.0814.76
ROIC
-0.15-0.13-0.19-0.14-0.07
Return on tangible assets
-0.33-0.3-0.52-0.37-0.24
Graham Net
0.79-0.49-1.84-1.54-2.19
Working capital
3.01M1.35M-506K-373K-1.15M
Tangible asset value
4.25M2.6M695K798K-54K
Net current asset value
2.13M573K-1.2M-1.03M-1.74M
Invested capital
0.090.090.080.080.1
Average receivables
1.04M995.5K947K871K1.18M
Average payables
2.34M2.09M2.12M2.3M2.46M
Average inventory
652.5K685.5K627K541.5K586.5K
Days sales outstanding
38.83927.4122.5235.71
Days payables outstanding
107.86102.595.3199.99122.06
Days of inventory on hand
33.5435.5423.7622.3530.89
Receivables turnover
2.322.313.2842.52
Payables turnover
0.830.880.940.90.74
Inventory turnover
2.682.533.794.032.91
ROE
-0.17-0.14-0.21-0.16-0.11
Capex per share
-0.1-0.05-0.02-0.03-0.02

PRPO Frequently Asked Questions

What is Precipio, Inc. stock symbol ?

Precipio, Inc. is a US stock , located in New haven of Ct and trading under the symbol PRPO

What is Precipio, Inc. stock quote today ?

Precipio, Inc. stock price is $6.7 today.

Is Precipio, Inc. stock public?

Yes, Precipio, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap